Personal information

Verified email domains

Biography

Masaaki Miyazawa, M.D., Ph.D.
Professor Emeritus, Kindai University, Higashiosaka, Osaka, Japan
Visiting Professor of Immunology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan
Senior Director, Research and Development Center for Nasal Mucosal Vaccine, Shin Nippon Biomedical Laboratories, Kagoshima, Japan

Born September 15, 1956 in Iida, Nagano, Japan

Education:
1982 Graduated from Tohoku University School of Medicine, Sendai, Japan with honors. M.D. (Tohoku University)
1982 Physician's License (Ministry of Health, Labor and Welfare of Japan)
1982 Entered Division of Medical Sciences, Graduate School of Tohoku University, Sendai, Japan with the highest mark
1983 Left the Graduate School of Tohoku University to take an offered faculty position
1987 Ph.D. in Medical Sciences (Tohoku University)
1994 Licensed to practice autopsies (Ministry of Health, Labor and Welfare of Japan)
1995 Board-certified diagnostic pathologist (Japanese Society of Pathologists)

Occupation:
1984-1995 Research Associate of Pathology, Tohoku University School of Medicine, Sendai, Japan
1986-1990 Visiting Associate, NIH, NIAID, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, Hamilton, MT, U.S.A.
1990-1995 Teaching staff, Division of Medical Sciences, Graduate School of Tohoku University, Sendai, Japan
1990-1995 Visiting Diagnostic Pathologist, Sendai Municipal Hospital, Sendai, Japan
1990-1995 Lecturer of Pathology, Sendai Municipal School of Nursing, Sendai, Japan
1992-1995 Lecturer of Pathology, Shokei Women’s College, Natori, Japan
1994 Senior Lecturer of Bioregulation, Mie University School of Medicine, Tsu, Japan
1995 Associate Professor, Department of Bioregulation, Mie University School of Medicine, Tsu, Japan
1996-2023 Professor and Head of the Department of Immunology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan; Professor, Kindai University Graduate School of Medical Sciences, Osaka-Sayama, Japan
1998-2022 Director, Laboratory of Living Modified Organisms (P3/P3A; BSL3), Central Research Facilities, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
2001-2011 Professor and Director, Division of Medical Informatics, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
2002-2008 Professor, Kindai University International Center for Human Sciences, Higashiosaka, Japan
2003-2022 Chief Biosafety Officer, Kindai University, Higashiosaka, Japan
2003-2012 Lecturer of Immunology, Graduate School of Health Sciences, Kobe University, Kobe, Japan
2004-2022 Principal Examiner of Biology, Entrance Examination Committee, Kindai University Faculty of Medicine
2005-date Lecturer of Histology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan
2006-2022 Member, Kindai University Liaison Center, Higashi-Osaka, Japan
2009-2022 Member, Kindai University Anti-Aging Center, Higashi-Osaka, Japan
2011-2022 Principal Professor of Medical English, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
2012-data Lecturer of Clinical Immunology, Kindai University Faculty of Biology-Oriented Science and Technology, Kinokawa, Japan
2012-2016 Chairman of the Administrative Committee, Kindai University Graduate School of Medical Sciences, Osaka-Sayama, Japan
2015-2022 Director, Central Research Facilities, Kindai University Faculty of Medicine, Osaka-Sayama, Japan
2016-2022 Vice Chairman, Kindai University Entrance Examination Committee, Higashi-Osaka, Japan
2016-2023 Dean, Kindai University Graduate School of Medical Sciences, Osaka-Sayama, Japan
2018-data Lecturer of Pathology, Kochi University Medical School, Nankoku, Kochi, Japan
2023 Retired from Kindai University due to the obligatory age-limit, Professor Emeritus, Kindai University, Higashiosaka, Japan
2023-date Senior Director, Research and Development Center for Nasal Mucosal Vaccine, Shin Nippon Biomedical Laboratories, Kagoshima, Japan

Activities

Employment (6)

Shin Nippon Biomedical Laboratories (Japan): Kagosima, JP

2023-04-01 to present | Senior Director (Research and Development Center for Nasal Mucosal Vaccine)
Employment
Source: Self-asserted source
Masaaki Miyazawa

Kindai University: Osaka, JP

2023-04-01 to present | Professor Emeritus
Employment
Source: Self-asserted source
Masaaki Miyazawa

Kindai University: Osaka-Sayama, Osaka, JP

1996-04-01 to 2023-03-31 | Professor and Department Head (Department of Immunology)
Employment
Source: Self-asserted source
Masaaki Miyazawa

Mie University Faculty of Medicine: Tsu, Mie, JP

1995-08-01 to 1996-03-31 | Associate Professor (Department of Biregulation)
Employment
Source: Self-asserted source
Masaaki Miyazawa

Tohoku University School of Medicine: Sendai, Miyagi, JP

1984-01-01 to 1995-07-31 | Research Associate (Department of Pathology)
Employment
Source: Self-asserted source
Masaaki Miyazawa

National Institute of Allergy and Infectious Diseases: Hamilton, MT, US

1986-09-01 to 1990-01-15 | Visiting Associate (Laboratory of Persistent Viral Diseases)
Employment
Source: Self-asserted source
Masaaki Miyazawa

Education and qualifications (4)

Tohoku University: Sendai, Miyagi, JP

1997-06-30 to present | PhD
Qualification
Source: Self-asserted source
Masaaki Miyazawa

Ministry of Health Labour and Welfare: Tokyo, JP

1982-06-30 to present | Physician's License
Qualification
Source: Self-asserted source
Masaaki Miyazawa

Tohoku University Graduate School of Medical Sciences: Sendai, Miyagi, JP

1982-04-01 to 1983-12-31 (Major in Pathology)
Education
Source: Self-asserted source
Masaaki Miyazawa

Tohoku University School of Medicine: Sendai, Miyagi, JP

1976-04-01 to 1982-03-31 | MD
Education
Source: Self-asserted source
Masaaki Miyazawa

Professional activities (5)

Sigma Xi: Durham, North Carolina, US

2022-01-01 to present
Membership
Source: Self-asserted source
Masaaki Miyazawa

American Society for Microbiology: Washington, DC, US

1988-09-01 to present
Membership
Source: Self-asserted source
Masaaki Miyazawa

Japanese Society of Pathology: Tokyo, JP

1982-04-01 to present (Meritorious Member)
Membership
Source: Self-asserted source
Masaaki Miyazawa

Japanese Society for Immunology: Tokyo, JP

1982-04-01 to present
Membership
Source: Self-asserted source
Masaaki Miyazawa

Japan Rheumatism Foundatiuon : Tokyo, JP

2002-04-21 | Novartis Rheumatism Research Award
Distinction
Source: Self-asserted source
Masaaki Miyazawa

Funding (34)

Elucidation of the mechanisms for leukemogenesis in Friend-virus infected mice

2019-04-01 to 2022-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 19K07581
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

レトロウイルス中和抗体産生制御遺伝子の実体と作用機序の解明

2019-04-01 to 2022-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 19H03481
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Development of new treatment for ovarian cancer based on intratumor heterogeneity

2018-04-01 to 2023-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 18H02947
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

超微小転移リンパ節の精密診断と新化学療法に関する総合的研究

2018-04-01 to 2021-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 18H03544
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

APOBEC3によるGag-Pol前駆体プロセシング阻害の機序解明

2016-04-01 to 2019-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 16K08821
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

マウスAPOBEC3のプロテアーゼ抑制機構解明による新規抗レトロウイルス薬開発

2016-04-01 to 2019-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 16H05199
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

レトロウイルス誘発がん制御におけるB細胞TLR7シグナルの重要性

2016-04-01 to 2019-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 16K08749
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

卵巣癌のゲノム多様性に基づく播種・転移・薬剤耐性・免疫逃避機序の解明と臨床応用

2016-04-01 to 2019-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 16H05477
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

細胞内複製制限因子APOBEC3の進化要因としての異種由来レトロウイルス

2015-04-01 to 2017-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 15H01268
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Development of early diagnosis and treatment for lymph node metastasis

2014-04-01 to 2017-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 26242051
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Autophagy regulation by HIV-1 Vpr

2013-04-01 to 2016-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 25460573
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Retroviral immune evasion

2013-04-01 to 2016-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 25460507
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Mechanisms of regulation of host immune responses by retrovirus-restricting enzyme APOBEC3

2012-04-01 to 2015-03-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 24390116
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

The role of mouse APOBEC3 in the regulation of endogenous retrovirus

2010-01-01 to 2012-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 22590352
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Regulation of APOBEC3 gene expression and its transcript splicing

2009-01-01 to 2011-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 21390143
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Mechanisms of the control of chromosome 22 gene expression associated with HIV-1-exposed but uninfected status

2005-01-01 to 2006-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 17390137
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

A new human endogenous retrovirus for the pathogenesis of systemic lupus erythematosus

2003-01-01 to 2004-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 15591145
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Analyses of host genes that confer immune resistance against human immunodeficiency virus type-1 infection in HIV-1-exposed but uninfected individuals in the overseas cohorts

2003-01-01 to 2004-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 15406021
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Molecular mechanisms of vascular injury in an autoantibody-induced model of granulomatous arteritis

2003-01-01 to 2004-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 15591504
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

細胞傷害性Tリンパ球はウイルス感染防御に必要か

2003-01-01 to 2004-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 15659099
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Structural analysis of protective and non-protective T-cell epitopes encoded with in the retroviral gag gene product

2001-01-01 to 2002-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 13670305
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Elucidation of Pathoptysiological Roles of Immune Chemokines

1999-01-01 to 2001-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 11470091
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

MECHANISMS OF PROTECTION AGAINST RETROVIRAL INFECTIONS INDUCED WITH A SINGLE-EPITOPE CD4^+ T-CELL VACCINE

1999-01-01 to 2000-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 11670307
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Engineering of a novel oral herpesvirus vaccine using a gene therapy

1997-01-01 to 1999-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 09670238
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

CD4陽性T細胞はどのようにウイルス感染細胞を排除するか

1997-01-01 to 1998-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 09877052
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

C型肝炎ウィルス特異的ヘルパーTクローン樹立と抗原依存性TH1・TH2分化の検討

1996-01-01 to 1997-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 08877087
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Use of bovine-RBC-substituted SCID mice for the studies of Babesia parasites

1995-01-01 to 1997-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 07456146
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Mechanisms of tissue injury induced with anti-gp70 autoantibodies

1995-01-01 to 1996-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 07670230
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

多価合成ペプチドワクチンによるレトロウイルス感染防御免疫の誘導

1994-01-01 to 1994-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 06255201
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

モノクローナル抗体による血栓性血小板減少性紫斑病モデルの発症メカニズ

1993-01-01 to 1993-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 05770137
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

レトロウイルスGag抗原上の細胞障害性T細胞エピトープの同定と感染防御への応用

1993-01-01 to 1993-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 05262201
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

gag抗原合成ペプチドによるレトロウイルス感染防御免疫の誘導

1992-01-01 to 1992-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 04269201
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

レトロウイルスコア抗原による感染防御免疫の誘導

1991-01-01 to 1991-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 03219202
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Experimental Pathology of Granuloma Formation

1985-01-01 to 1987-12-31 | Grant
Japan Society for the Promotion of Science (Tokyo, JP)
GRANT_NUMBER: 60480150
Source: Self-asserted source
Masaaki Miyazawa via DimensionsWizard

Works (50 of 97)

Items per page:
Page 1 of 2

Adjusting Heterodimeric Coiled-Coils (K/E Zipper) to Connect Autophagy-Inducing Peptide with Cell-Penetrating Peptide

Pharmaceutics
2023-03-24 | Journal article
Contributors: Yoshiyuki Hakata; Kazuma Yamashita; Sonoko Hashimoto; Takashi Ohtsuki; Masaaki Miyazawa; Mizuki Kitamatsu
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Anti-prion activity of cellulose ether is impaired in mice lacking pre T-cell antigen receptor α, T-cell receptor δ, or lytic granule function

International Immunopharmacology
2022-06 | Journal article
Part of ISSN: 1567-5769
Source: Self-asserted source
Masaaki Miyazawa

Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells

Viruses
2022-04-17 | Journal article
Contributors: Shota Tsukimoto; Yoshiyuki Hakata; Sachiyo Tsuji-Kawahara; Takuji Enya; Tetsuo Tsukamoto; Seiya Mizuno; Satoru Takahashi; Shinichi Nakao; Masaaki Miyazawa
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

DOCK8-expressing T follicular helper cells newly generated beyond self-organized criticality cause systemic lupus erythematosus

iScience
2022-01 | Journal article
Part of ISSN: 2589-0042
Source: Self-asserted source
Masaaki Miyazawa

An autopsy case of acute myocarditis with unique lymph node findings characterized by the proliferation of reactive plasmablasts

Journal of Clinical and Experimental Hematopathology
2020 | Journal article
Part of ISSN: 1346-4280
Part of ISSN: 1880-9952
Source: Self-asserted source
Masaaki Miyazawa

Intracellular delivery of a peptide nucleic acid-based hybrid of an autophagy inducing peptide with a cell-penetrating peptide

Organic & Biomolecular Chemistry
2020 | Journal article
Contributors: Yoshiyuki Hakata; Suzuka Ishikawa; Takashi Ohtsuki; Masaaki Miyazawa; Mizuki Kitamatsu
Source: check_circle
Crossref

Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection

Inflammation and Regeneration
2020-12 | Journal article
Contributors: Masaaki Miyazawa
Source: check_circle
Crossref

Deaminase-Independent Mode of Antiretroviral Action in Human and Mouse APOBEC3 Proteins

Microorganisms
2020-12-12 | Journal article
Contributors: Yoshiyuki Hakata; Masaaki Miyazawa
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection

European Respiratory Journal
2020-06 | Journal article
Part of ISSN: 0903-1936
Part of ISSN: 1399-3003
Source: Self-asserted source
Masaaki Miyazawa

Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing

PLOS Pathogens
2019-12-12 | Journal article
Contributors: Yoshiyuki Hakata; Susan R. Ross; Jun Li; Takahiro Fujino; Yuki Tanaka; Rie Shimizu; Masaaki Miyazawa
Source: check_circle
Crossref

U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation

Journal of Clinical Investigation
2019-12-03 | Journal article
Part of ISSN: 0021-9738
Part of ISSN: 1558-8238
Source: Self-asserted source
Masaaki Miyazawa

Interstitial-resident memory CD8+ T cells sustain frontline epithelial memory in the lung

Journal of Experimental Medicine
2019-12-02 | Journal article
Part of ISSN: 0022-1007
Part of ISSN: 1540-9538
Source: Self-asserted source
Masaaki Miyazawa

A leucine zipper-based peptide hybrid delivers functional Nanog protein inside the cell nucleus.

Bioorganic & medicinal chemistry letters
2019-02 | Journal article
Contributors: Hakata Y; Michiue H; Ohtsuki T; Miyazawa M; Kitamatsu M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Impact of Daylight Saving Time on circadian timing system: An expert statement.

European journal of internal medicine
2019-01 | Journal article
Contributors: Meira E Cruz M; Miyazawa M; Manfredini R; Cardinali D; Madrid JA; Reiter R; Araujo JF; Agostinho R; Acuña-Castroviejo D
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.

Clinical cancer research : an official journal of the American Association for Cancer Research
2018-03 | Journal article
Contributors: Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.

Journal of virology
2017-06 | Journal article
Contributors: Fujino M; Sato H; Okamura T; Uda A; Takeda S; Ahmed N; Shichino S; Shiino T; Saito Y; Watanabe S et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis.

Gastroenterology
2016-11 | Journal article
Contributors: Yoshikawa T; Wu J; Otsuka M; Kishikawa T; Suzuki N; Takata A; Ohno M; Ishibashi R; Yamagami M; Nakagawa R et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance.

The Journal of experimental medicine
2016-11 | Journal article
Contributors: Takamura S; Yagi H; Hakata Y; Motozono C; McMaster SR; Masumoto T; Fujisawa M; Chikaishi T; Komeda J; Itoh J et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

[Functional polymorphisms and molecular evolution of mouse APOBEC3].

Seikagaku. The Journal of Japanese Biochemical Society
2016-10 | Journal article
Contributors: Miyazawa M; Hakata Y; Takeda E; Li J; Tsuji-Kawahara S
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

A novel leucine zipper motif-based hybrid peptide delivers a functional peptide cargo inside cells.

Chemical communications (Cambridge, England)
2014-11 | Journal article
Contributors: Hakata Y; Tsuchiya S; Michiue H; Ohtsuki T; Matsui H; Miyazawa M; Kitamatsu M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.

Journal of virology
2014-11 | Journal article
Contributors: Kato M; Tsuji-Kawahara S; Kawasaki Y; Kinoshita S; Chikaishi T; Takamura S; Fujisawa M; Kawada A; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.

Virology journal
2014-06 | Journal article
Contributors: Hakata Y; Miyazawa M; Landau NR
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Reply to "CD8+ T cells are essential for controlling acute friend virus infection in C57BL/6 mice".

Journal of virology
2014-05 | Journal article
Contributors: Tsuji-Kawahara S; Takamura S; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Infection of adult thymus with murine retrovirus induces virus-specific central tolerance that prevents functional memory CD8+ T cell differentiation.

PLoS pathogens
2014-03 | Journal article
Contributors: Takamura S; Kajiwara E; Tsuji-Kawahara S; Masumoto T; Fujisawa M; Kato M; Chikaishi T; Kawasaki Y; Kinoshita S; Itoi M et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Elimination of friend retrovirus in the absence of CD8+ T cells.

Journal of virology
2013-11 | Journal article
Contributors: Tsuji-Kawahara S; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Differential requirements of cellular and humoral immune responses for Fv2-associated resistance to erythroleukemia and for regulation of retrovirus-induced myeloid leukemia development.

Journal of virology
2013-10 | Journal article
Contributors: Tsuji-Kawahara S; Kawabata H; Matsukuma H; Kinoshita S; Chikaishi T; Sakamoto M; Kawasaki Y; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

IFN-γ-producing effector CD8 T lymphocytes cause immune glomerular injury by recognizing antigen presented as immune complex on target tissue.

Journal of immunology (Baltimore, Md. : 1950)
2013-05 | Journal article
Contributors: Tsumiyama K; Hashiramoto A; Takimoto M; Tsuji-Kawahara S; Miyazawa M; Shiozawa S
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

[Molecular evolution of physiologically functioning anti-retroviral APOBEC3 deaminases].

Uirusu
2012-06 | Journal article
Contributors: Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

In vivo diagnostic imaging using micro-CT: sequential and comparative evaluation of rodent models for hepatic/brain ischemia and stroke.

PloS one
2012-02 | Journal article
Contributors: Hayasaka N; Nagai N; Kawao N; Niwa A; Yoshioka Y; Mori Y; Shigeta H; Kashiwagi N; Miyazawa M; Satou T et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Two genetic determinants acquired late in Mus evolution regulate the inclusion of exon 5, which alters mouse APOBEC3 translation efficiency.

PLoS pathogens
2012-01 | Journal article
Contributors: Li J; Hakata Y; Takeda E; Liu Q; Iwatani Y; Kozak CA; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

A hole in the T-cell repertoire induced after retroviral infection of immunocompetent adult mice.

Retrovirology
2011-10 | Journal article
Contributors: Miyazawa M; Takamura S; Tsuji-Kawahara S; Kajiwara E; Chikaishi T; Kato M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases.

Molecular biology and evolution
2011-06 | Journal article
Contributors: Sironi M; Guerini FR; Agliardi C; Biasin M; Cagliani R; Fumagalli M; Caputo D; Cassinotti A; Ardizzone S; Zanzottera M et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Attenuated food anticipatory activity and abnormal circadian locomotor rhythms in Rgs16 knockdown mice.

PloS one
2011-03 | Journal article
Contributors: Hayasaka N; Aoki K; Kinoshita S; Yamaguchi S; Wakefield JK; Tsuji-Kawahara S; Horikawa K; Ikegami H; Wakana S; Murakami T et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.

Journal of virology
2011-03 | Journal article
Contributors: Ogawa T; Tsuji-Kawahara S; Yuasa T; Kinoshita S; Chikaishi T; Takamura S; Matsumura H; Seya T; Saga T; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Diversity of MHC class I genes in Burmese-origin rhesus macaques.

Immunogenetics
2010-07 | Journal article
Contributors: Naruse TK; Chen Z; Yanagida R; Yamashita T; Saito Y; Mori K; Akari H; Yasutomi Y; Miyazawa M; Matano T et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Protection of macaques with diverse MHC genotypes against a heterologous SIV by vaccination with a deglycosylated live-attenuated SIV.

PloS one
2010-07 | Journal article
Contributors: Sugimoto C; Watanabe S; Naruse T; Kajiwara E; Shiino T; Umano N; Ueda K; Sato H; Ohgimoto S; Hirsch V et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.

Journal of virology
2010-04 | Journal article
Contributors: Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.

Journal of immunology (Baltimore, Md. : 1950)
2010-03 | Journal article
Contributors: Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Mouse APOBEC3 affects the production of virus-neutralizing antibodies by restricting early retroviral replication, not by altering the B-cell repertoire.

Retrovirology
2009-09 | Journal article
Contributors: Miyazawa M; Tsuji-Kawahara S; Chikaishi T; Kato M; Takamura S
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

The 'immunologic advantage' of HIV-exposed seronegative individuals.

AIDS (London, England)
2009-01 | Journal article
Contributors: Miyazawa M; Lopalco L; Mazzotta F; Lo Caputo S; Veas F; Clerici M; ESN Study Group
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.

Journal of virology
2008-09 | Journal article
Contributors: Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Decreased expression of intestinal chemokine TECK/CCL25 in experimental obstructive jaundice and its reversal following internal biliary drainage.

Journal of gastroenterology
2008-07 | Journal article
Contributors: Matsumoto T; Ajiki T; Kajiwara E; Mita Y; Fujita T; Morimoto H; Miyazawa M; Ku Y
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Host genetic factors that control immune responses to retrovirus infections.

Vaccine
2008-01 | Journal article
Contributors: Miyazawa M; Tsuji-Kawahara S; Kanari Y
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

HIV resistance genes

2007-07 | Patent
OTHER-ID:

ZA200706090

Contributors: MASAAKI MIYAZAWA; MARIO CLERICI; SHINJI IRIE
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Reference strand-mediated conformation analysis-based typing of multiple alleles in the rhesus macaque MHC class I Mamu-A and Mamu-B loci.

Electrophoresis
2007-03 | Journal article
Contributors: Tanaka-Takahashi Y; Yasunami M; Naruse T; Hinohara K; Matano T; Mori K; Miyazawa M; Honda M; Yasutomi Y; Nagai Y et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.

The Journal of infectious diseases
2007-02 | Journal article
Contributors: Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.

The Journal of general virology
2007-02 | Journal article
Contributors: Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

MHC class I-like MILL molecules are beta2-microglobulin-associated, GPI-anchored glycoproteins that do not require TAP for cell surface expression.

Journal of immunology (Baltimore, Md. : 1950)
2006-09 | Journal article
Contributors: Kajikawa M; Baba T; Tomaru U; Watanabe Y; Koganei S; Tsuji-Kawahara S; Matsumoto N; Yamamoto K; Miyazawa M; Maenaka K et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

Increased liver temperature efficiently augments human cellular immune response: T-cell activation and possible monocyte translocation.

Cancer immunology, immunotherapy : CII
2006-02 | Journal article
Contributors: Kida Y; Tsuji-Kawahara S; Ostapenko V; Kinoshita S; Kajiwara E; Kawabata H; Yuasa T; Nishide I; Yukawa S; Ichinose M et al.
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central

HIV resistance genes

2005-12 | Patent
OTHER-ID:

CN101155827

Contributors: MASAAKI MIYAZAWA; SHINJI IRIE; MARIO CLERICI
Source: Self-asserted source
Masaaki Miyazawa via Europe PubMed Central
Items per page:
Page 1 of 2

Peer review (6 reviews for 3 publications/grants)

Review activity for Inflammation and regeneration. (2)
Review activity for Molecular biology reports. (1)
Review activity for PLOS pathogens : (3)